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The ability to maintain proper airway surface liquid (ASL) volume
homeostasis is vital for mucus hydration and clearance, which are
essential aspects of the mammalian lung’s innate defense system.
In cystic fibrosis (CF), one of the most common life-threatening
genetic disorders, ASL dehydration leads to mucus accumulation
and chronic infection. In normal airways, the secreted protein
short palate lung and nasal epithelial clone 1 (SPLUNC1) effectively
inhibits epithelial Na+ channel (ENaC)-dependent Na+ absorption
and preserves ASL volume. In CF airways, it has been hypothesized
that increased ENaC-dependent Na+ absorption contributes to ASL
depletion, and hence increased disease. However, this theory is
controversial, and the mechanism for abnormal ENaC regulation
in CF airways has remained elusive. Here, we show that SPLUNC1
is a pH-sensitive regulator of ENaC and is unable to inhibit ENaC in
the acidic CF airway environment. Alkalinization of CF airway cul-
tures prevented CF ASL hyperabsorption, and this effect was abol-
ished when SPLUNC1 was stably knocked down. Accordingly, we
resolved the crystal structure of SPLUNC1 to 2.8 Å. Notably, this
structure revealed two pH-sensitive salt bridges that, when re-
moved, rendered SPLUNC1 pH-insensitive and able to regulate
ASL volume in acidic ASL. Thus, we conclude that ENaC hyperac-
tivity is secondary to reduced CF ASL pH. Together, these data
provide molecular insights into the mucosal dehydration associ-
ated with a range of pulmonary diseases, including CF, and sug-
gest that future therapy be directed toward alkalinizing the pH of
CF airways.
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The epithelial Na+ channel (ENaC) is the rate-determiningstep for Na+ absorption across the colon, kidney, and lung
(1). ENaC is a heterotrimer consisting of α-, β-, and γ-subunits (2).
The extracellular domains of the α- and γ-ENaC subunits must be
proteolytically cleaved by serine proteases, such as trypsin or neu-
trophil elastase, or by intracellular furin-type convertases in order
for the channel to become active and to conduct Na+ (2, 3). In
contrast, the β-subunit is highly glycosylated and not cleaved
but may form a regulatory subunit that governs ENaC surface
densities (1, 4). In some cases, ENaC may bypass the steps
required for proteolysis and be inserted into the plasma membrane
as near-silent, inactive channels (5). Abnormal ENaC activity has
been linked with the pathogenesis of several diseases, including
cystic fibrosis (CF), Liddle syndrome, and salt-sensitive hyperten-
sion (6). In CF airways, the absence of functional cystic fibrosis
transmembrane conductance regulator (CFTR) in the apical
plasma membrane causes ENaC hyperactivity, and the resulting
excessive Na+ absorption contributes to airway surface liquid
(ASL) dehydration, mucus stasis, and bacterial infections (7).
Similar lung disorders have been observed in transgenic mice
either overexpressing β-ENaC or exhibiting altered regulation
of ENaC by the ubiquitin protein ligase NEDD4L, thus link-
ing Na+ hyperabsorption and ASL volume depletion to the
development of pulmonary disease (4, 8). However, whether or
not ENaC activity is up-regulated in CF airways is currently
controversial (9). Part of this problem may lie in the lack of an
identified mechanism for ENaC hyperactivity in CF airways.
Thus, although ENaC has been shown to be up-regulated in
vivo, in freshly isolated human airway tissues, and in cell cul-
ture, no mechanism for this up-regulation has been discovered
(10–13).
Normal but not CF airway cultures autoregulate ASL volume
by coordinating CFTR and ENaC activity via soluble “reporter
molecules” that, by virtue of their dilution and concentration,
transmit information on ASL volume to the epithelia (14). The
short palate lung and nasal epithelial clone 1 (SPLUNC1), the
most abundant secreted protein in the airways, is one such re-
porter molecule and is absolutely required for limiting ENaC
activity and maintaining normal ASL homeostasis (14, 15). We
have previously shown that SPLUNC1 binds to ENaC, causing it
to be internalized, thus protecting ENaC from proteolytic cleavage
and activation (15). SPLUNC1 is also a secreted protein that
has been proposed to share homology with the N-terminal do-
main of bacterial permeability-increasing protein (BPI) (16).
Despite the presence of SPLUNC1 in CF ASL (17, 18), CF
airway cultures are unable to regulate ENaC (19). Importantly,
CF ENaC is not fully dysfunctional and is sensitive to exogenous
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protease inhibitors, suggesting that the defect lies elsewhere (19).
CFTR conducts HCO3
−, which maintains ASL at near-neutral pH,
and when CFTR is defective (20), the ASL becomes more
acidic (21). Because SPLUNC1–ENaC interactions are extra-
cellular, we hypothesized that an acidified ASL prevented
SPLUNC1 from inhibiting ENaC. To test this hypothesis, we
examined the relationship between SPLUNC1-dependent reg-
ulation of ENaC and the ASL pH. To explore this interaction
further, we resolved the crystal structure of SPLUNC1 to ∼2.8
Å and used this structure to understand better how ENaC is
regulated in CF airway cultures.
Results
As previously described, we found that SPLUNC1 was present in
CF ASL (17, 19) (Fig. S1). We then verified that CF ASL pH was
abnormally low in CF subjects. In agreement with previous
studies (21, 22), CF ASL pH was ∼0.5 units lower than normal
ASL pH in vivo (Fig. 1A). Stimulation of glandular secretion
with chili peppers abolished this difference, which is consistent
with a previous report in which the pH of glandular secretions
derived from normal subjects and subjects with CF was not dif-
ferent (23), and inhibition of glands with ipratropium preserved it
(Fig. 1A). Together, these data indicate that the surface epithelial
cells are responsible for the observed pH difference.
To determine if ASL pH has functional effects on ENaC ac-
tivity in vivo, we measured the amiloride-sensitive potential dif-
ference (PD) at pH 7.4 vs. 6.0 as a marker of ENaC activity.
Lowering the pH significantly raised the amiloride-sensitive PD
in normal subjects, indicating that ENaC is sensitive to changes
in extracellular pH in vivo (Fig. 1B). Normal and CF airway
cultures replicate the in vivo pH difference (Fig. 1C). CF airway
cultures show significantly increased ENaC proteolysis (12). To
test if ENaC proteolysis was pH-dependent, we clamped normal
and CF ASL pH at 6.0 or 7.4 for 1 h (Fig. S2 A and B) and then
performed apical surface biotinylation followed by Western blot
analysis using an antibody that recognizes cleaved γ-ENaC. In
both normal and CF airway cultures, ENaC cleavage was greater
at acidic pH (Fig. 1D and Fig. S3). Raising ASL HCO3
− levels
has been proposed as a therapy for the treatment of acidic CF
ASL (24). To test whether alkalization prevented CF ASL
hyperabsorption, we added 20 μL of high-bicarbonate, isotonic
Ringer solution mucosally. This maneuver had no effect on
normal ASL height, which remained at ∼7 μm (Fig. 1 E and F).
However, the addition of bicarbonate Ringer solution slowed
ASL absorption on CF airway culture surfaces (i.e., height was
kept in the range that enables cilia to beat and clear mucus),
suggesting that ASL pH has functional consequences for ENaC
activity and ASL volume regulation.
Because ENaC cleavage and ASL height regulation were pH-
sensitive, we next tested whether SPLUNC1 regulated ENaC in
a pH-dependent manner. As described (15), stable knockdown
of SPLUNC1 abolished ASL height regulation in normal air-
way cultures and was restored with recombinant SPLUNC1
(rSPLUNC1; Fig. 2 A and B). In contrast, neither SPLUNC1
knockdown nor rSPLUNC1 addition had any effect on CF ASL
height, suggesting that SPLUNC1 cannot function properly in
CF airways (Fig. 2B). Furthermore, the positive effect of bi-
carbonate addition on CF ASL height was lost when SPLUNC1
was knocked down. Crucially, addition of both rSPLUNC1 and
bicarbonate was required to increase CF ASL height, indicating
that the ability of SPLUNC1 to regulate ENaC/ASL height is
pH-dependent (Fig. 2B).
To test whether the SPLUNC1–ENaC interaction was pH-
dependent, we measured fluorescent rSPLUNC1 binding to the
apical surface of normal and CF airway cultures when the pH
was clamped over the range of 6.0–7.5 by mucosal addition of
a modified, isotonic Ringer solution, where pH was set with
100 mM of either MES (pH 6.0 or pH 6.5) or HEPES (pH 7.0
or pH 7.5). Binding was pH-dependent in both normal and CF
airway cultures, with significantly more binding at pH ≥7.0 (Fig. 2
C and D). Inhibition of the amiloride-sensitive transepithelial PD
(Vt), as a marker of ENaC activity, was also pH-dependent in
both normal and CF airway cultures (Fig. 2 E and F), as was
ASL height (Fig. S2 C–F). However, a peptide corresponding to
the SPLUNC1 region important for ENaC inhibition (S18; amino
acids G22–A39) inhibited ENaC in a pH-independent fashion
(Fig. 2 E and F). This S18 peptide also bound to ENaC and
prevented its cleavage in a pH-independent fashion (Fig. S4).
As a control, we added SPLUNC1Δ44, which lacks the S18 re-
gion, and this had no effect on ENaC activity (Fig. 2 E and F).
rSPLUNC1 did not bind to HEK 293T cells unless they were
transfected with αβγ-ENaC, and the pH dependency was
preserved in this system, indicating that binding was ENaC-
dependent (Fig. 3A). The pH-dependent inhibition of ENaC
by SPLUNC1 was preserved in Xenopus oocytes expressing
αβγ-ENaC, providing further evidence that this is an ENaC-
mediated effect (Fig. 3B).
To unravel the molecular basis of this activity, we determined
crystal structures of human rSPLUNC1 in both low and high salt
(Fig. 4A, Fig. S5A, and Tables S1 and S2). SPLUNC1 is a mono-
mer composed of a central six-stranded, antiparallel β-sheet
flanked by six α-helices (Fig. 4A and Fig. S5 B and C), and it
exhibits structural similarity to the N-terminal half of BPI (Fig.
5). Unfortunately, the S18 region of SPLUNC1 that is required for
ENaC inhibition was not ordered in our structures. Furthermore,
although intact SPLUNC1 functions in a pH-dependent manner,
the S18 peptide alone is pH-independent, which could suggest a
conformational change in SPLUNC1 (Figs. 2 E and F and 3 A
Fig. 1. Bicarbonate addition increases ASL height in CF airways. (A) CF ASL
pH is reduced in vivo. Nasal secretions obtained under basal conditions (n =
18 normal subjects and 7 subjects with CF) or after chili pepper alone (n = 7
normal subjects and 5 subjects with CF) or ipratropium alone (n = 7 normal
subjects and 5 subjects with CF) exposure. (B) Amiloride (Amil)-sensitive PD
was measured following nostril exposure to pH 7.4 or pH 6.0 Ringer solution
(n = 7 normal subjects). (C) ASL pH was measured in normal and CF airway
cultures (n = 12 for both). (D) Representative Western blots showing cleaved
surface γ-ENaC 1 h postexposure to pH 6.0 or pH 7.4 solution. NL, normal. (E)
Representative x–z confocal images showing preservation of ASL (red) on CF
airway cultures following exposure to 20 μL of Ringer solution or modified
Ringer solution with 100 mM NaHCO3
− instead of 100 mM NaCl. Bicarb,
bicarbonate. (F) Mean data from E (n = 8 for all). Open bars represent
normal subjects, and closed bars represent subjects with CF. *P < 0.05, dif-
ference between normal subjects and subjects with CF; †P < 0.05, difference
from control subjects. (Scale bar: 7 μm.) Error bars represent SE.
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and B and Fig. S4). However, we did not detect any changes in
SPLUNC1 secondary structure when examined by CD spectro-
polarimetry at different pH (Fig. S6). Thus, we hypothesized that
structural features of the surface of SPLUNC1 are involved in
presenting the S18 region to ENaC.
The electrostatic surface of SPLUNC1 features a cluster of
charged residues (D112, K138, R152, and D193) in close
proximity to residue 43, onto which the S18 peptide (amino
acids G22–A39) is fused (Fig. 4 B and C). We reasoned that this
relatively conserved cluster of amino acids (Fig. S7) is important
for SPLUNC1 function. To examine this prediction, we created
rSPLUNC1 proteins with either D193 mutated to N or R152
replaced with E. Unlike WT rSPLUNC1, these mutant proteins
functioned in a pH-independent manner; they were able to
maintain proper ASL hydration (Fig. 4D) and bind the surface
of airway cultures (Fig. 4E) at both pH 6.0 and pH 7.5. Our
data indicate that these residues form a salt bridge (Fig. S8),
which, when disrupted, causes SPLUNC1 to regulate ENaC in
a pH-insensitive manner. Strikingly, when the potential salt bridge
was “restored” in a double mutant in which the positions of the
residues were swapped, D193R/R152D, ASL hydration, and air-
way culture binding were again pH-sensitive. A second pair of
surface residues, D112 and K138, gave similar results (Fig. S8).
Although it is possible that ENaC contributes to this pH
sensitivity, taken together, our data pinpoint a site on SPLUNC1
that controls the presentation of S18 to ENaC and governs
the pH-dependent regulation of ASL volume in normal but not
CF airways.
Discussion
The etiology of CF lung disease is controversial and has been
ascribed to ASL volume depletion, reduced ASL pH, altered
mucus rheology, decreased bacterial killing, and more (22, 25–
28). These differences may not be mutually exclusive; for ex-
ample, impaired bacterial killing has recently been attributed to
reduced ASL pH (22) and impaired mucus clearance due to
either low ASL volume or altered mucus rheology would in-
crease the chance of bacterial colonization (29). Here, we found
that acidity in CF ASL is causal for increased ENaC cleavage/
activity and CF ASL volume depletion, suggesting that many of
the defects in CF lung innate defense have a similar etiology,
namely, reduced ASL pH. Gastric reflux is common in subjects
with CF and has also been linked with lung disease in patients
who do not have CF (30, 31). Thus, in addition to the reduced
pH caused by CFTR’s absence, exposure of very low pH due to
gastric reflux may further exacerbate this issue in patients with
CF and contribute to a failure of mucus clearance in patients
who do not have CF and are prone to gastric reflux.
Consistent with previous observations that CF ASL pH is re-
duced due to the lack of bicarbonate secretion through CFTR
and associated proteins (21, 32), we detected a decrease in CF
ASL pH that was associated with increased ENaC activity in vivo
and in vitro (Fig. 1). Airway epithelia are leaky, and there is
a continual backflux of ions through the paracellular pathway
that appears to limit this difference to ∼0.5 units (Fig. 1). Due to
the large paracellular permeability for physiological ions and
a large serosal reservoir of Cl−, the concentration of Cl− is not
different between normal and CF ASL (27). Because there is
a large submucosal reservoir of HCO3
−, it is perhaps surprising
that there is reduced CF ASL pH, especially because there is
a diffusion gradient for HCO3
− into the ASL. However, an
H+/K+ ATPase has previously been reported in the apical mem-
brane of airway epithelia (21). Thus, the difference in ASL pH
Fig. 2. SPLUNC1 is a pH-dependent regulator of ENaC. (A) SPLUNC1 ex-
pression relative to GAPDH following stable shRNA knockdown of luciferase
(control) or SPLUNC1 knockdown. KD, knockdown. (B) Mean ASL height
following luciferase or SPLUNC1 KD in normal (open bars; n = 9) and CF
(closed bars; n = 6) airway cultures and following addition of rSPLUNC1,
high-bicarbonate Ringer solution, or both. Normal (C) and CF (D) airway
cultures bind Alexa 488–labeled rSPLUNC1 in a pH-dependent manner (n ≥
9). AU, arbitrary units. Normal (E) and CF (F) airway cultures exhibit changes
in Vt (n > 6 for all). rSPLUNC1, red; vehicle, black; S18, blue; rSPLUNC1
Δ44,
green. *P < 0.05, difference between vehicle/control/pH 6.0 as appropriate;
†P < 0.05, difference between normal and CF. Error bars represent SE. For E
vs. F, data for control/vehicle and rSPLUNC1Δ44 were all significantly differ-
ent between normal and CF cultures at corresponding pH; statistical symbols
were omitted for clarity.
Fig. 3. SPLUNC1–ENaC interactions are pH-dependent. (A) Fluorescence
intensity of Alexa 488-rSPLUNC1 binding to nontransfected (NT) or
αβγ-ENaC–transfected HEK 293T cells over the pH range of 6.0–7.5 (n ≥ 9 for
all). (B) Effect of rSPLUNC1 and S18 on the amiloride-sensitive ENaC current.
αβγ-ENaC subunits were injected into Xenopus oocytes and incubated for 1 h
with 30 μM of either rSPLUNC1 or S18, and the relative ENaC current was
measured by a two-electrode voltage clamp (n = 9–12 for all). *P < 0.05,
significant difference from rSPLUNC1; †P < 0.05, significant difference from
rSPLUNC1, pH 6. Data are plotted as mean ± SE.








between normal and CF ASL may reflect active cellular H+ se-
cretion that outstrips passive paracellular HCO3
− diffusion.
Surprisingly, our data indicated that glandular secretions did not
contribute to the observed pH difference seen in CF nasal
secretions. This is in agreement with previous studies of secretions
from isolated normal vs. CF human airway glands, where the pH
was not altered in CF (23), and suggests that CFTR is not involved
in pH regulation in human submucosal glands.
As previously described, knockdown of SPLUNC1 abolished
the natural restraint on ENaC, and standard ASL height was
restored only with rSPLUNC1 addition in normal airway cultures
(15). Despite the presence of SPLUNC1 in CF ASL (Fig. S1),
SPLUNC1 knockdown was without effect in CF airway cultures
and both bicarbonate and rSPLUNC1 were required to restore
ASL homeostasis (Fig. 2). Thus, our data strongly suggest that
Na+ hyperabsorption was secondary to altered ASL pH and that
altered SPLUNC1–ENaC interactions are the physiological
mechanism of Na+ hyperabsorption in CF airways. In earlier
studies, it was proposed that altered ENaC sensitivity to cAMP
in CF airways was the cause of Na+ hyperabsorption (11, 33).
However, these studies were performed under “thick-film”
conditions, where the endogenous ASL was washed away and
epithelial pH was clamped at pH 7.4. Conversely, our experi-
ments were performed with a “thin film” of ASL that more ac-
curately reprises the situation in the lung. Despite this, we cannot
exclude the possibility that cAMP metabolism is pH-sensitive
and different between normal and CF airway cultures or that
cAMP affects SPLUNC1–ENaC interactions. Importantly, the
pH dependency of SPLUNC1 in vitro matched the normal vs. CF
pH differences in vivo, and binding was increased by 50% from
pH 6.5 to pH 7.0 (Fig. 2 C and D), which was mirrored by an
equal or greater gain in functionality (Fig. 2 E and F). Although
the pH dependency was broadly similar between normal and CF
cultures, we consistently saw more binding/function in normal
HBECs than in CF HBECs at pH 6.5 and the slope of the curves
was also different (Fig. 2 and Fig. S2 C and D). As a result, we
hypothesize that CFTR confers a change in ENaC conformation
that facilitates increased SPLUNC1 binding at higher pH in
normal airways. Furthermore, although our data with heterolo-
gous expression systems suggest that the pH dependency is
largely due to ENaC–SPLUNC1 interactions, it is also possible
that SPLUNC1 binds to other proteins either in the ASL or on
Fig. 4. Human SPLUNC1 crystal structure. (A) X-ray crystal structure (resolution of 2.8 Å) of residues 43–254 of human rSPLUNC1 with secondary structural
elements indicated. (B) Electrostatic surface representation of human SPLUNC1 showing positively (blue) and negatively (red) charged regions. (C) Close-up of
Asp-112, Lys-138, Arg-152, and Asp-193 on the surface of human SPLUNC1 shown in the same orientation as in A and B. (D) Fluorescence intensity of Alexa
488-labeled rSPLUNC1 mutant proteins (30 μM) binding to the apical surface of normal airway cultures (n ≥ 5). (E) Mean ASL height in normal airway cultures
2 h after addition of 30 μM SPLUNC1 mutant proteins in modified Ringer solution at pH 6.0 or pH 7.5 (n ≥ 9). *P < 0.05, significant difference between pH 6.0
(red bars) and pH 7.5 (blue bars) for a given mutant; †P < 0.05, significance vs. rSPLUNC1, pH 7.5. Error bars represent SE.
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the cell surface. Indeed, SPLUNC1 is a multifunctional protein
that can regulate ENaC, facilitate bacterial killing, and affect
ASL surface tension. However, the effects of SPLUNC1 binding
to other proteins remain to be explored (15, 34, 35).
As predicted (16), SPLUNC1 shares significant structural
similarity with human BPI (Fig. 5). The most striking difference
between the two proteins lay at SPLUNC1’s C-terminal region,
where, in the structure presented here, a unique α6-helix in
SPLUNC1 occludes the equivalent lipid-binding site in BPI
(Fig. 5). This unique region may be responsible for the addi-
tional roles that SPLUNC1 plays in lung defense, such as S18-
mediated regulation of ENaC. Whereas full-length SPLUNC1
is strongly pH-dependent, S18 can bind to and inhibit ENaC in
a pH-independent fashion (Fig. 2 and Figs. S2 and S4). Despite
this, the secondary structure of SPLUNC1 was not altered be-
tween the range of pH 6.0 and pH 7.5 (Fig. S5A), and further
investigation revealed that the S18 region of SPLUNC1 (i.e.,
residues G22–A39) was disordered, and hence not visible, on the
SPLUNC1 crystal structure. However, the structure revealed
surface features essential to the pH-dependent regulation of
ENaC, such as an electrostatic region (Fig. 4). This surface elec-
trostatic patch is essentially conserved in the primate SPLUNC1s,
as is the sequence of S18, and we note that as the sequence of S18
diverges from that of the human protein, so does the identity of
the residues in the electrostatic surface patch examined here.
Thus, SPLUNC1 proteins from species more distantly related
to humans, like mouse and rat, do not completely maintain the
surface residues and also contain an S18 region that is dif-
ferent (i.e., 16–24 residues longer) than the human S18. Thus,
we speculate that SPLUNC1 function, and pH-sensitivity, will
vary from species to species.
In conclusion, we posit that the region encompassing R152
and D193 is required for the proper availability of S18 and for
SPLUNC1 regulation of ENaC/ASL homeostasis. We propose
that the failure of SPLUNC1 to regulate CF ASL height is due to
inappropriate interactions between the S18 and R152/D193
regions at an acidic pH that precludes SPLUNC1 binding to
ENaC. Taken together, our data establish key molecular features
essential for controlling ENaC activity and provide detailed
insights into the pH-dependent misregulation of ENaC associ-
ated with CF lung disease. Furthermore, our data indicate that
normalization of CF ASL pH may be a treatment option that can
restore SPLUNC1-dependent regulation of ENaC and help
prevent the mucus dehydration seen in CF airways.
Materials and Methods
This section is a summary of the most important techniques used. A detailed
description of all methods can be found in SI Materials and Methods.
Expression and Purification of Human SPLUNC1. SPLUNC1 cDNA was kindly
provided by Colin Bingle (University of Sheffield, Sheffield, United Kingdom).
BL21-CodonPlus competent cells (Agilent Technologies) were transformed
with the expression plasmid and cultured in the presence of antifoam (50 μL),
ampicillin (100 μg/mL), and chloramphenicol (34 μg/mL) in LB with vigorous
shaking at 37 °C until an OD600 of 0.6 was attained. Expression was induced
with the addition of 0.1 mM isopropyl-1-thio-D-galactopyranoside (IPTG),
temperature was decreased to 18°C, and bacteria were cultured overnight.
Cell pellets were resuspended in buffer A [20 mM potassium phosphate (pH
7.4), 50 mM imidazole, 500 mM NaCl, 0.02% NaAzide], along with lysozyme,
DNase1, and protease inhibitor tablets. Cells were sonicated, and cell lysate
was separated into insoluble and soluble fractions, which were filtered and
flowed over an Ni-NTA His-Trap gravity column and washed with buffer A.
The bound protein was eluted with buffer B [20 mM potassium phosphate
(pH 7.4), 500 mM imidazole, 500 mM NaCl, 0.02% NaAzide] and separated
using an S200 gel filtration column on an ÄKTAxpress (GE Healthcare Life
Sciences). Nickel and size exclusion chromatography, and tobacco etch virus
protease removed the tag from purified SPLUNC1.We confirmed that SPLUNC1
purified in this fashion inhibited ENaC in normal airway cultures (n = 6).
Study Subjects. The study protocol was approved by the University of North
Carolina Committee on the Protection of Rights of Human Subjects, and
written informed consent was obtained. All normal subjects had no history of
chronic rhinitis and no acute nasal symptoms for at least 2 wk before sam-
pling. None took any chronic medication. The mean age of normal subjects
was 25.4 ± 1.06 y. All subjects with CF were homozygous for ΔF508, and their
mean age was 28.2 ± 2.67 y.
In Vivo Nasal PDs and Nasal Secretions.Nasal PDwas measured between an s.c.
reference electrode and an exploring electrode placed against the inferior
turbinate as described (36).
ASL pH Measurement and pH Clamping. ASL pH was measured with pH-
sensitive microelectrodes (Microelectrodes) in small-volume samples that could
be quickly temperature-, water vapor-, and gas-equilibrated as described (21).
When indicated, apical pH was clamped by adding 20 μL of modified Ringer
solution containing either 100 mM HEPES (pH 7.0 and pH 7.5) or 100 mM
MES (pH 6.0 and pH 6.5) at 37 °C with 5% CO2 gas in air. To verify that pH
was clamped appropriately, pH-sensitive pHrodo dextran (10 μM) and pH-
insensitive Alexa 647 dextran (10 μM) were added to the Ringer solution and
measured in situ on airway cultures at timed intervals at 585 nm and 668 nm,
respectively, using a Tecan Infinite M1000 plate reader at 37 °C.
Cell Culture. Human donor lungs and excised recipient lungs were obtained
from main stem/lobar bronchi of CF or normal lungs, using protocols ap-
proved by the University of North Carolina Committee on the Protection of
the Rights of Human Subjects (15). shRNA-induced knockdown of SPLUNC1
was performed using retrovirus as described (15).
ASL Height Measurements. ASL was labeled by adding 20 μL of Ringer solution
containing 10 kDa of Texas red or FITC dextran at 1 mg/mL to the apical
surface and measured using a Leica SP5 confocal microscope with a 63×
glycerol immersion objective, as described previously (15).
Fluorescence-Based Binding Assay. SPLUNC1 and peptides were labeled on
their N terminus with Dylight-488 amine-reactive dye (Thermo Scientific) per
kit instructions. Fluorescent proteins/peptides were then added apically to
airway cultures in 20 μL of modified Ringer solution, incubated for 1 h, and
imaged with a Nikon Ti-S microscope using a 60× water immersion objective
lens at 484 nM (emission >517 nm). Total fluorescence was quantified using
ImageJ software (National Institutes of Health).
Vt Studies. A single-barreled Vt-sensing electrode was positioned in the ASL
by micromanipulator and used in conjunction with a macroelectrode in the
serosal solution to measure Vt using a voltmeter (15).
Fig. 5. Human SPLUNC1 (blue) shares structural similarity with the N-ter-
minal half of human BPI (yellow). Residues 43–254 of SPLUNC1 were
superimposed on residues 1–194 of BPI, and the two structures were found
to share an rmsd of 3.8 Å over 157 Ca positions with only 12% sequence
identity. Thus, SPLUNC1 appears to represent half of the complete BPI.
Amino acids 1, 45, 97, 194, and 456 of the BPI are labeled for clarity, as are
amino acids 43 and 254 and α-helices 1, 2, 4, 5, and 6 of SPLUNC1. It is in-
teresting to note that helix 6 of SPLUNC1 in the structure presented here is
located in a position that occludes the lipid-binding pocket of BPI; however,
one can envision a conformational change that may open an analogous
pocket in SPLUNC1.








Crystallization of rSPLUNC1. Initial crystals of purified rSPLUNC1 (residues
20–256) were grown in low salt using hanging drop vapor diffusion in 8%
(vol/vol) PEG-400, 0.2 M trisodium citrate, and 0.1 M Tris·HCL (pH 8.5). These
crystals were cryoprotected in 20% PEG-400 and were used for initial data
collection and determination of a preliminary model using single-wavelength
anomalous dispersion (SAD) methods to a resolution of 3.2 Å. A variant form
of human rSPLUNC1 (L68M/L157M) was generated to produce signal suffi-
cient for SAD phasing. Improved crystals of WT human rSPLUNC1 (residues 20–
256) were grown in high-salt 6 M ammonium nitrate and 0.1 M Tris·HCL (pH
8.5) and cryoprotected in 15% glycerol. A crystal from these higher salt con-
ditions was used to collect the data used for final structure determination and
refinement at a resolution of 2.8 Å (Table S1).
Structure Determination and Refinement. Initial human rSPLUNC1 crystals
diffracted X-rays to a resolution of only 3.2 Å but were sufficient to de-
termine initial phases using SAD methods. rSPLUNC1 (L68M/L157M) was
created using PCR mutagenesis. This created a form of human SPLUNC1 that
contained three total methionines, and this recombinant protein was la-
beled with selenomethionine using standard Escherichia coli methods. Data
were collected at the peak wavelength for selenium anomalous scattering;
the exact wavelength, as well as f′ and f′′, was calculated from a fluores-
cence scan obtained at Advance Photon Source National Institute of General
Medical Sciences and the National Cancer Institute Collaborative Access
Team beamline 23. SPLUNC1 low-salt crystals displayed anisotropic diffrac-
tion and a very high Wilson B-factor of 104 Å2. These data, which exhibited
a resolution of 100-3.2 Å (Table S2), were sufficient to locate the selenium
sites from the selenomethionines using Python-Based Hierarchical Environ-
ment for Integrated Xtallography (PHENIX) (www.phenix-online.org). The
anomalous signal was calculated to be 0.07–0.08 to a resolution of 4.5 Å.
There were six selenium sites per asymmetrical unit in the P4 unit cell.
Electron density maps calculated from the selenium phases, including den-
sity modification in PHENIX (RESOLVE), had mostly continuous electron
density with both α-helices and β-sheets easily discerned. Using the
selenomethionine sites as sequence markers, a model with two human
rSPLUNC1 monomers in the asymmetrical unit was built that encompassed
the final six β-sheets and six α-helices, as well as some loop regions. Re-
finement was initiated to improve the electron density in all areas; some of
the loops, however, were not visualized, and the average thermal dis-
placement parameter for the protein model was 103 Å2 (Table S2). Large
cavities were evident in the crystal packing, and the solvent content of the
crystals was 70%, which may partially explain the low diffraction resolution
and high thermal motions observed.
At this point, a splunc1 crystal form was discovered in 6 M ammonium
nitrate that diffracted to 2.8 Å with space group C2221 (see Table S1). We
then used molecular replacement with a single monomer of our preliminary
SPLUNC1 model from the low-salt data as a search model. Molecular re-
placement revealed two clear monomers in the asymmetric unit using the
data from the high-salt crystals. Refinement was completed with PHENIX and
manual adjustments in the Crystallographic Object-Oriented Toolkit using
standard methods, and produced a highly improved final model with reason-
able Wilson B-factors and average thermal displacement parameters of 70 Å2
and 74 Å2, respectively (Table S1).
Statistical Analyses. Data were analyzed with the Student t test or ANOVA
followed by the Tukey test, where the variances were homogeneously dis-
tributed. All values are expressed as mean ± SEM, and P < 0.05 was con-
sidered statistically significant. Airway cultures derived from three or more
donors were used per experiment, and experiments using cell lines were
repeated on at least three separate occasions. All analyses were conducted
using Instat (GraphPad) or Prism 5 (GraphPad) software.
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